Aims and Scope


The journal primarily focus on providing a world-class open access publishing experience within the reach for all the professionals working in this area of research. The journal become itself an excellent source of scientific information and provide an open platform to read, share and distribute the latest research updates.
Blood cancers, or hematologic cancers is a broad subject that includes various types of neoplasms that includes Leukemia - Cancer that originates in blood-forming tissue, lymphoma: Cancer that develops in the lymphatic system, Hodgkin lymphoma - marked by the presence of an abnormal lymphocyte called the B lymphocyte, Multiple myeloma - Cancer that begins in the blood's plasma cells. All the blood cancers are diagnosed and treated with various sophisticated techniques that are advancing day-by-day. Continuous research is enabling emergence of new technologies that make the healthcare more effective and the updated research information is needed to be reached to all the clinical and medical professionals. Our journal plays a key role in disseminating the scientific knowledge within its scope.


  • Bruising
  • Acute promyelocyticleukaemia (APL)
  • Blood loss
  • Bone marrow
  • Chronic myelomonocyticleukaemia (CMML)
  • Hairy cell leukaemia (HCL)
  • Immune system
  • Large granular lymphocytic leukaemia (LGL)
  • Leukemia
  • Lymphoblastic
  • Lymphoma
  • Myeloma
  • Radiation Therapy
  • Stem-cell transplant
  • T-cell acute lymphoblastic leukaemia (T-ALL)

Subscribe to Our Newsletter